celastrol has been researched along with Hepatic Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anamalai, M; Deshmukh, S; Kaushal, S; Mishra, R; Patel, J; Sharma, S; Simpson, D; Singh, IS; Walker, BL; Zampino, M | 1 |
1 other study(ies) available for celastrol and Hepatic Failure
Article | Year |
---|---|
Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.
Topics: Animals; Apoptosis; Cardiomyopathies; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Doxorubicin; GATA4 Transcription Factor; Gene Expression; Heat Shock Transcription Factors; Heat-Shock Proteins; Humans; Interleukin-1beta; Interleukin-6; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pentacyclic Triterpenes; Thioacetamide; Transcription Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |